Relapse · group A streptococcal pharyngitis
Cephalosporins may leads to lower incidence of relapse (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Adverse events (ITT analysis) · group A streptococcal pharyngitis
It is very uncertain whether cephalosporins changes adverse events (ITT analysis) compared with penicillin (very low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (ITT analysis) · group A streptococcal pharyngitis
Macrolides showed no clear difference in resolution of symptoms post‐treatment (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (evaluable participants) · group A streptococcal pharyngitis
Macrolides showed no clear difference in resolution of symptoms post‐treatment (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Relapse · group A streptococcal pharyngitis
Macrolides showed no clear difference in incidence of relapse (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Adverse events (ITT analysis) · group A streptococcal pharyngitis
Macrolides showed no clear difference in adverse events (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Clinical cure · group A streptococcal pharyngitis
It is very uncertain whether azithromycin changes clinical cure (ITT analysis) compared with amoxicillin (very low certainty).
1 finding from 1 review
Time to resolution of acute illness · children with acute pneumonia
1 finding from 1 review
Number of days in hospital (duration of hospitalisation) · children with acute pneumonia
1 finding from 1 review
Mortality rate ( · children with acute pneumonia
Vitamin D showed no clear difference in mortality rate ( compared with placebo (low certainty).
1 finding from 1 review
Mortality within 28 days · people with acute respiratory infections
1 finding from 1 review
Number of participants in need of a hospital admission within 28 days · people with acute respiratory infections
1 finding from 1 review
Clinical recovery · people with acute respiratory infections
The review found no eligible studies for this question.
2 findings from 1 review
Clinical recovery · people with acute respiratory infections
2 findings from 1 review
Mortality within 28 days · people with acute respiratory infections
1 finding from 1 review
Number of participants in need of a hospital admission within 28 days · people with acute respiratory infections
1 finding from 1 review
Overall mortality · adults receiving mechanical ventilation for at least 48 hours
Topical plus systemic prophylaxis leads to lower overall mortality compared with placebo or no treatment (high certainty).
1 finding from 1 review
Respiratory tract infections ‐ topical plus systemic prophylaxis versus systemic prophylaxis alone · adults receiving mechanical ventilation for at least 48 hours
Topical prophylaxis showed no clear difference in respiratory tract infections ‐ topical plus systemic prophylaxis… compared with no topical prophylaxis (low certainty).
1 finding from 1 review
Respiratory infections · adults receiving mechanical ventilation for at least 48 hours
Topical prophylaxis may leads to lower respiratory tract infections ‐ topical prophylaxis versus no… compared with no topical prophylaxis (low certainty).
2 findings from 1 review
Dropouts due to adverse events · adults receiving mechanical ventilation for at least 48 hours
It is very uncertain whether topical prophylaxis changes dropouts due to adverse events compared with no topical prophylaxis (very low certainty).
1 finding from 1 review